Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
UTI Annual Interval Fund - II - Regular Plan - IDCW
★★★★★ 3rd-party
External rating
- Source: Third-party data provider (Groww/CRISIL)
- Original rating: 2/5, displayed as-is — TopFund does not modify third-party ratings
- Refresh frequency: Whenever TopFund re-syncs this fund's data
- Limitations: The provider's own rating methodology isn't disclosed here — see the provider's own site for their criteria
TopFund Score: 55/100 · Average
How this score is calculated
- Star rating (35%)2/5
- 3Y CAGR (30%)3.5%
- Expense ratio (20%)0.25%
- AUM (15%)₹29,603 Cr
Not investment advice — an analytical read of public fund data. Methodology →
UTI Mutual Fund · IDF · Large Cap
₹11.12
AUM: ₹29,602 Cr
NAV updated 1 day ago
Plan
Regular
Option
Idcw
Risk
High
Expense Ratio
0.25%
Exit Load
Nil
Fund Manager
Kaushik Basu
Inception
Jan 2013
Benchmark
NIFTY 50 Total Return Index
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
+0.45%
3m
+1.52%
6m
+3.12%
1y
+6.82%
3y
+3.5%
5y
+2.16%
10y
+1.06%
since inception
+0.6%
TopFund's Take on UTI Annual Interval Fund - II - Regular Plan - IDCW
UTI Annual Interval Fund - II - Regular Plan - IDCW sits in the middle of the pack for Large Cap funds, currently carrying a 2-star rating. Returns have been soft relative to what the category has offered — worth checking if this is a temporary phase or a longer pattern. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 55/100.
Cost: At 0.25%, the expense ratio is meaningfully cheaper — about 58% below the Large Cap category average of 0.6% (based on 452 comparable funds). Lower costs compound in your favour over long holding periods.
Risk-adjusted performance: Risk-adjusted return metrics (Sharpe ratio, standard deviation) require at least a year of NAV history and aren't available yet for this fund.
Who should invest: This fund is best suited to conservative equity investors or those wanting a stable core holding, typically with a 3+ year horizon. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Asset Allocation
Fund Snapshot
Similar Funds
No similar funds found.
Tools & Guides for This Fund
Frequently Asked Questions about UTI Annual Interval Fund - II - Regular Plan - IDCW
The current NAV (Net Asset Value) of UTI Annual Interval Fund - II - Regular Plan - IDCW is ₹11.12. NAV is updated every business day after market close by AMFI.
1Y: 6.82% · 3Y CAGR: 3.5% · 5Y CAGR: 2.16%
The expense ratio of UTI Annual Interval Fund - II - Regular Plan - IDCW is 0.25% per annum. This is the annual fee charged by the fund to manage your investment.
UTI Annual Interval Fund - II - Regular Plan - IDCW is managed by Kaushik Basu at UTI Mutual Fund.
UTI Annual Interval Fund - II - Regular Plan - IDCW is classified as a High risk fund. It is suitable for investors with a long-term horizon of 3+ years.
Yes, UTI Annual Interval Fund - II - Regular Plan - IDCW is an equity fund, making it suitable for SIP investments. Regular monthly SIPs help average out market volatility through rupee-cost averaging.
You can start a SIP in UTI Annual Interval Fund - II - Regular Plan - IDCW with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
The Assets Under Management (AUM) of UTI Annual Interval Fund - II - Regular Plan - IDCW is ₹29,603 crore. AUM indicates the total market value of assets managed by the fund.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.